Cheap Medicine Shop/www.cheapmedicineshop.com – FDA Warning Letter, Sep 2, 2026

On September 24, 2026, the U.S. Food and Drug Administration (FDA) issued a warning letter to Cheap Medicine Shop (www.cheapmedicineshop.com), an India-based online pharmacy. This action followed a regulatory review of the website conducted on August 26 and September 2, 2026. The FDA identified that the company is illegally selling unapproved and misbranded injectable drug products, specifically a semaglutide product marketed as "Semanext Injection." The agency emphasized that injectable medications carry high risks, including potential contamination or life-threatening conditions like sepsis, and noted that these products have not been evaluated for safety or effectiveness. The company is in violation of the Federal Food, Drug, and Cosmetic Act, which prohibits the distribution of new drugs without proper approval and requires medication labels to provide adequate directions for safe use. Because "Semanext Injection" is a prescription drug intended for conditions that require professional medical supervision, the FDA determined it cannot be used safely by a layperson based on the current labeling. The FDA has ordered Cheap Medicine Shop to immediately stop offering these unapproved medications to the American public. The company is required to investigate the root cause of these issues, implement corrective actions, and provide a written response to the FDA within 15 business days. Failure to address these violations may result in legal consequences, including the seizure of products or court-ordered injunctions.